http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200105299-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b02a0b178545b772f5459d938a584583
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0047
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1eb19506e0e3b13226e567f34c223ee
publicationDate 2020-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200105299-A
titleOfInvention Ultrasound-driven drug delivery platforms by the use of nanobubbles water prepared with drug-conjugated phospholipids via ester bonds and preparation method thereof
abstract The present invention relates to a phospholipid-based drug delivery system to which a drug is bound through a linker containing an ester bond, a composition for drug delivery comprising the drug delivery system and nanobubble water, a method for preparing the phospholipid-based drug delivery system, and the composition to a human It relates to a method for preventing or treating diseases comprising the step of administering to an individual except for the step of releasing a drug by irradiating ultrasound to a site to which the composition is administered. When the drug delivery system of the present invention is administered to an individual in a form dissolved in nanobubble water, the hydrolysis of the ester bond is smoothly performed according to the ultrasonic irradiation, thereby synergistically increasing the release rate of the target drug. The target drug can be delivered.
priorityDate 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID285033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71311796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572499
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5477614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428402173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426078444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15061530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036

Total number of triples: 34.